^
BIOMARKER:

ERCC1 overexpression

i
Other names: ERCC1, RAD10, Excision repair cross-complementation group 1
Entrez ID:
Related biomarkers:
ERCC1 overexpression
CRC
oxaliplatin
Resistant: C3 – Early Trials
ERCC1 overexpression
Sarcoma
doxorubicin hydrochloride + trabectedin
Sensitive: C3 – Early Trials
ERCC1 overexpression
Soft Tissue Sarcoma
trabectedin
Sensitive: C3 – Early Trials
ERCC1 overexpression
HER2 Positive Breast Cancer
trastuzumab
Resistant: C3 – Early Trials
ERCC1 overexpression
SCCHN
cisplatin + 5-fluorouracil
Sensitive: C3 – Early Trials